Surgical indications for combined partial rectosigmoidectomy in ovarian cancer

Journal of Obstetrics and Gynaecology Research

Volumn 31, Issue 6, 2005, Pages 556-561

  Takahashi, Osamu ^a   Sato, Naoki ^a   Miura, Yoshinori ^a   Ogawa, Masaki ^a   Fujimoto, Toshio ^a   Tanaka, Hidenori ^a   Sato, Hirokazu ^a   Tanaka, Toshinobu ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bowel resection; Ovarian cancer; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; COLON SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OVARIECTOMY; OVARY ADENOCARCINOMA; OVARY CANCER; RECTOSIGMOIDECTOMY; RECTUM; RECTUM CANCER; RECTUM SURGERY; SIGMOID; SIGMOID CARCINOMA; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; COLON, SIGMOID; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; RECTUM;

EID: 30344467524     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2005.00336.x     Document Type: Article

References (20)

1. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Elashoff RM. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 1983; 61: 413-420.
2. Hoskins WJ, McGuire WP, Brady MF et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994; 170: 974-980.
3. DiSaia PJ, Tewari KS. Recent advancements in the treatment of epithelial ovarian cancer. J Obstet Gynaecol Res 2001; 27: 61-75.
4. Lichtenegger W, Sehouli J, Buchmann E, Karajanev C, Weidemann H. Operative results after primary and secondary debulking-operations in advanced ovarian cancer (AOC). J Obstet Gynaecol Res 1998; 24: 447-451.
5. Kato T, Shimizu Y, Umezawa S, Hasumi K. [Rectosigmoidectomy following neoadjuvant chemotherapy for advanced ovarian cancer]. Nippon Sanka Fujinka Gakkai Zasshi 1994; 46: 1337-1342 (in Japanese).
6. Eisenkop SM, Nalick RH, Teng NN. Modified posterior exenteration for ovarian cancer. Obstet Gynecol 1991; 78: 879-885.
7. Barnes W, Johnson J, Waggoner S, Barter J, Potkul R, Delgado G. Reverse hysterocolposigmoidectomy (RHCS) for resection of panpelvic tumors. Gynecol Oncol 1991; 42: 151-155.
8. Weber AM, Kennedy AW. The role of bowel resection in the primary surgical debulking of carcinoma of the ovary. J Am Coll Surg 1994; 179: 465-470.
9. Sonnendecker EW, Beale PG. Rectosigmoid resection without colostomy during primary cytoreductive surgery for ovarian carcinoma. Int Surg 1989; 74: 10-12.
10. Soper JT, Couchman G, Berchuck A, Clarke-Pearson D. The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma. Gynecol Oncol 1991; 41: 239-244.
11. Berek JS, Hacker NF, Lagasse LD. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Obstet Gynecol 1984; 64: 715-720.
12. Obermair A, Hagenauer S, Tamandl D et al. Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 2001; 83: 115-120.
13. Bristow RE, del Carmen MG, Kaufman HS, Montz FJ. Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer. J Am Coll Surg 2003; 197: 565-574.
14. Shimada M, Kigawa J, Minagawa Y, Irie T, Takahashi M, Terakawa N. Significance of cytoreductive surgery including bowel resection for patients with advanced ovarian cancer. Am J Clin Oncol 1999; 22: 481-484.
15. Clayton RD, Obermair A, Hammond IG, Leung YC, McCartney AJ. The Western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy. Gynecol Oncol 2002; 84: 53-57.
16. Gillette-Cloven N, Burger RA, Monk BJ et al. Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer. J Am Coll Surg 2001; 193: 626-632.
17. Scarabelli C, Gallo A, Franceschi S et al. Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma. Cancer 2000; 88: 389-397.
18. Jaeger W, Ackermann S, Kessler H, Katalinic A, Lang N. The effect of bowel resection on survival in advanced epithelial ovarian cancer. Gynecol Oncol 2001; 83: 286-291.
19. Goff BA, Sainz de la Cuesta R, Muntz GH et al. Clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 1996; 60: 412-417.
20. McGuire WP, Hoskins WJ, Brady MF et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1-6.